Compile Data Set for Download or QSAR
Report error Found 40 Enz. Inhib. hit(s) with all data for entry = 3491
TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261482(US9708266, 5 | US10011568, Ex. No. 5)
Affinity DataIC50: 0.980nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261483(US9708266, 6 | US10011568, Ex. No. 6)
Affinity DataIC50: 1nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261478(US9708266, 1 | US10011568, Ex. No. 1)
Affinity DataIC50: 1.45nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261490(US9708266, 13 | US10011568, Ex. No. 13)
Affinity DataIC50: 1.62nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261484(US9708266, 7 | US10011568, Ex. No. 7)
Affinity DataIC50: 1.63nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261479(US9708266, 2 | US10011568, Ex. No. 2)
Affinity DataIC50: 1.78nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261480(US9708266, 3 | US10011568, Ex. No. 3)
Affinity DataIC50: 2.10nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261491(US9708266, 14 | US10011568, Ex. No. 14)
Affinity DataIC50: 2.21nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261481(US9708266, 4 | US10011568, Ex. No. 4)
Affinity DataIC50: 2.35nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261486(US9708266, 9 | US10011568, Ex. No. 9)
Affinity DataIC50: 2.35nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261497(US9708266, 21 | US10011568, Ex. No. 21)
Affinity DataIC50: 2.36nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261492(US9708266, 16 | US10011568, Ex. No. 16)
Affinity DataIC50: 2.78nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261487(US9708266, 10 | US10011568, Ex. No. 10)
Affinity DataIC50: 2.79nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261496(US9708266, 20 | US10011568, Ex. No. 20)
Affinity DataIC50: 3.27nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261485(US9708266, 8 | US10011568, Ex. No. 8)
Affinity DataIC50: 4.01nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261489(US9708266, 12 | US10011568, Ex. No. 12)
Affinity DataIC50: 4.46nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261495(US9708266, 19 | US10011568, Ex. No. 19)
Affinity DataIC50: 4.96nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261493(US9708266, 17 | US10011568, Ex. No. 17)
Affinity DataIC50: 5.51nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261494(US9708266, 18 | US10011568, Ex. No. 18)
Affinity DataIC50: 6.45nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261488(US9708266, 11 | US10011568, Ex. No. 11)
Affinity DataIC50: 6.75nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM50220136(CHEMBL1471 | 5-(((2R,3S)-2-((R)-1-(3,5-bis(trifluo...)
Affinity DataIC50: 20nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261489(US9708266, 12 | US10011568, Ex. No. 12)
Affinity DataIC50: 2.20E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261488(US9708266, 11 | US10011568, Ex. No. 11)
Affinity DataIC50: 2.70E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261492(US9708266, 16 | US10011568, Ex. No. 16)
Affinity DataIC50: 3.10E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261493(US9708266, 17 | US10011568, Ex. No. 17)
Affinity DataIC50: 3.30E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261497(US9708266, 21 | US10011568, Ex. No. 21)
Affinity DataIC50: 4.20E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261494(US9708266, 18 | US10011568, Ex. No. 18)
Affinity DataIC50: 4.90E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261496(US9708266, 20 | US10011568, Ex. No. 20)
Affinity DataIC50: 5.50E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261485(US9708266, 8 | US10011568, Ex. No. 8)
Affinity DataIC50: 6.10E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261483(US9708266, 6 | US10011568, Ex. No. 6)
Affinity DataIC50: 6.10E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261479(US9708266, 2 | US10011568, Ex. No. 2)
Affinity DataIC50: 6.80E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261486(US9708266, 9 | US10011568, Ex. No. 9)
Affinity DataIC50: 6.90E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261481(US9708266, 4 | US10011568, Ex. No. 4)
Affinity DataIC50: 7.10E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261491(US9708266, 14 | US10011568, Ex. No. 14)
Affinity DataIC50: 7.50E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261490(US9708266, 13 | US10011568, Ex. No. 13)
Affinity DataIC50: 8.20E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261480(US9708266, 3 | US10011568, Ex. No. 3)
Affinity DataIC50: 9.40E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261484(US9708266, 7 | US10011568, Ex. No. 7)
Affinity DataIC50: 1.10E+4nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261487(US9708266, 10 | US10011568, Ex. No. 10)
Affinity DataIC50: 1.10E+4nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261482(US9708266, 5 | US10011568, Ex. No. 5)
Affinity DataIC50: 1.30E+4nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261478(US9708266, 1 | US10011568, Ex. No. 1)
Affinity DataIC50: 1.30E+4nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent